Skip to main content
Research_

Lambert Initiative for Cannabinoid Therapeutics

Developing cannanbinoid therapeutics for mainstream medicine

The Lambert Initiative was founded in 2015, the outcome of an unprecedented pledge of $33.7 million to the University of Sydney by Barry and Joy Lambert.

The Lambert Initiative is a long-term research program that is exploring the medicinal potential of the cannabis plant.

The vision of the Lambert Initiative is to conduct the high quality research required to discover, develop and optimise safe and effective cannabinoid therapeutics in Australia and beyond.

The Lambert Initiative provides national and international leadership in the science of medicinal cannabinoids and in the discovery and development of cannabis-based medicines. Our activities span a wide spectrum of basic science and clinical activities, from plant science, cellular and preclinical pharmacology, to medicinal chemistry and drug discovery, with the ultimate goal of making cannabinoid-based medicines available to patients.

In parallel with its scientific endeavours, the Lambert Initiative also acts in an advocacy and educational capacity, providing synthesis of evidence and guidance for clinicians, targeting consumers, health professionals and politicians, while seeking to influence regulatory approaches and public health policy.

We are involved in over 20 research projects, including: